SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon

References

Page 1

	Year	Citations
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection Jennifer M. Dan, José Mateus, Yu Kato, Science	2021	3K
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019 Juanjuan Zhao, Quan Yuan, Haiyan Wang, Clinical Infectious Diseases	2020	2.7K
Analysis of Complex Survey Samples Thomas Lumley Journal of Statistical Software Survey (Human Research)EngineeringData ScienceReplication WeightsVariance Estimation	2004	2.2K
Spread of SARS-CoV-2 in the Icelandic Population Daníel F. Guðbjartsson, Agnar Helgason, Hákon Jónsson, New England Journal of Medicine	2020	1.4K
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans Jeffrey Seow, Carl Graham, Blair Merrick, Nature Microbiology	2020	1.4K
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study Silvia Stringhini, Ania Wisniak, Giovanni Piumatti, The Lancet	2020	1.1K
ESTIMATING PREVALENCE FROM THE RESULTS OF A SCREENING TEST Walter J. Rogan, Beth C. Gladen American Journal of Epidemiology Basis PropertiesPreventive MedicineMinimal CriteriaEstimating PrevalenceCancer Screening	1978	997
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors Sophie Uyoga, Ifedayo Adetifa, Henry Karanja, Science	2020	339
Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis Oyungerel Byambasuren, Magnolia Cardona, Katy Bell, Virus EpidemiologyDisease OutbreakCovid-19 EpidemiologyCovid-19Preventive Medicine	2020	258
Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area Farhaan Vahidy, Alan Pan, Hilda Ahnstedt, PLoS ONE	2021	238

Page 1